These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7066204)

  • 41. Antithrombin Milano: a new variant with monomeric and dimeric inactive antithrombin III.
    Wolf M; Boyer C; Tripodi A; Meyer D; Larrieu MJ; Mannucci PM
    Blood; 1985 Feb; 65(2):496-500. PubMed ID: 3967090
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pulmonary arterial thrombosis in a neonate with homozygous deficiency of antithrombin III: successful outcome following pulmonary thrombectomy and infusions of antithrombin III concentrate.
    Roman K; Rosenthal E; Razavi R
    Cardiol Young; 2000 May; 10(3):275-8. PubMed ID: 10824912
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Congenital anti-thrombin III deficiency with mesenteric venous thrombosis--functional and immunological estimations.
    Dale BM; Naujalis J; Barber S
    Pathology; 1984 Oct; 16(4):424-30. PubMed ID: 6522108
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Antithrombin III deficiency as a risk factor in postoperative thrombosis].
    Van Betsbrugge M
    Acta Chir Belg; 1985; 85(5):299-302. PubMed ID: 4082851
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunoelectrophoretic evidence of a thrombin-induced abnormality in a new variant of hereditary dysfunctional antithrombin III (AT III 'Vicenza').
    Barbui T; Finazzi G; Rodeghiero F; Dini E
    Br J Haematol; 1983 Aug; 54(4):561-5. PubMed ID: 6871107
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effective prophylaxis of thrombosis by antithrombin III concentrate in a pregnant woman with congenital antithrombin III deficiency: relations between plasma antithrombin III activity and the plasma levels of hemostatic molecular markers.
    Inomoto T; Takamoto M; Tamura R; Maegawa M; Kamada M; Takayanagi M
    Haemostasis; 1991; 21(3):147-54. PubMed ID: 1773985
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Uses of antithrombin III concentrate in congenital and acquired deficiency states.
    Bucur SZ; Levy JH; Despotis GJ; Spiess BD; Hillyer CD
    Transfusion; 1998 May; 38(5):481-98. PubMed ID: 9633563
    [No Abstract]   [Full Text] [Related]  

  • 48. [Clinical problems posed by the consumption of antithrombin III induced by heparin].
    Ferrer F; Augereau B; Angebault M; Vergoz D
    Phlebologie; 1984; 37(1):77-81. PubMed ID: 6718507
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transfusion studies in patients with familial antithrombin III (ATIII) deficiency: half-disappearance time of infused ATIII and influence of such infusion on platelet life-span.
    Winter JH; Fenech A; Bennett B; Douglas AS
    Br J Haematol; 1981 Nov; 49(3):449-53. PubMed ID: 7295588
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hereditary antithrombin III deficiency: biochemical aspects.
    Sas G
    Haematologia (Budap); 1984; 17(1):81-6. PubMed ID: 6724355
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment with AT III concentrates in hereditary and acquired AT III deficiency.
    Gromnica-Ihle E; Ziemer S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):307-13. PubMed ID: 2465221
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Heparin cofactor II determination--levels in normals and patients with hereditary antithrombin III deficiency and disseminated intravascular coagulation.
    Tran TH; Duckert F
    Thromb Haemost; 1984 Oct; 52(2):112-6. PubMed ID: 6395434
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Crossed immunoelectrophoresis of congenital antithrombin III (AT) III deficiency, with special reference to the effects of AT III concentrate].
    Matsuo T; Ohoki Y; Kobayashi H; Yamada T
    Rinsho Ketsueki; 1983 Aug; 24(8):1026-31. PubMed ID: 6645071
    [No Abstract]   [Full Text] [Related]  

  • 54. Regulation of thrombosis and hemostasis by antithrombin.
    Sakuragawa N
    Semin Thromb Hemost; 1997; 23(6):557-62. PubMed ID: 9469630
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antithrombin III "Northwick Park": a variant antithrombin with normal affinity for heparin but reduced heparin cofactor activity.
    Howarth DJ; Samson D; Stirling Y; Seghatchian MJ
    Thromb Haemost; 1985 Jun; 53(3):314-9. PubMed ID: 4049307
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Factor IX concentrate therapy and thrombosis: relation to changes in plasma antithrombin III.
    Hoffman C; Hultin MB
    Thromb Res; 1986 Jul; 43(2):143-51. PubMed ID: 3738857
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Annuloaortic ectasia associated with antithrombin III deficiency; report of a case].
    Fujiwara Y; Yamada T; Katsuyama K; Utsumi T
    Kyobu Geka; 2013 Jul; 66(7):589-92. PubMed ID: 23917140
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of antithrombin concentrate in treatment of hereditary antithrombin deficiency. An update.
    Rodgers GM
    Thromb Haemost; 2009 May; 101(5):806-12. PubMed ID: 19404531
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Atrial Septal Defect with Hereditary Deficiency of Antithrombin III].
    Naruse H; Sakamoto Y; Kinouchi K; Inoue T; Matsumura Y; Yoshitake M; Bando K; Hashimoto K
    Kyobu Geka; 2016 Jul; 69(7):508-10. PubMed ID: 27365061
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Some immunological investigations on antithrombin III 'Budapest'.
    Lane JL
    Br J Haematol; 1978 Nov; 40(3):459-70. PubMed ID: 107959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.